Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Clinical trial NCT01551173 · COMPLETED
Trial details
- NCT number
- NCT01551173
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-05-01
- Enrollment
- 436
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.